---
title: "Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299363077.md"
description: "Bristol Myers Squibb (BMY) shares fell 1.19% to $62.84 on Thursday, underperforming the broader market and key competitors like Johnson & Johnson and Pfizer. This marks the stock's third consecutive day of losses, leaving it 8.45% below its 52-week high. Trading volume reached 12.1 million, exceeding the 50-day average."
datetime: "2026-09-17T20:36:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299363077.md)
  - [en](https://longbridge.com/en/news/299363077.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299363077.md)
generator: "portal-rs"
---

# Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. (BMY) shed 1.19% to $62.84 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.14% to 7,637.76 and the Dow Jones Industrial Average rising 0.61% to 51,778.04.

This was the stock's third consecutive day of losses.

Bristol Myers Squibb Co. closed 8.45% below its 52-week high of $68.64, which the company achieved on August 19th.

The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 1.10% to $270.22, Pfizer Inc. (PFE) rose 0.66% to $27.64, and Abbott Laboratories (ABT) fell 0.13% to $102.23.

Trading volume (12.1 M) eclipsed its 50-day average volume of 10.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 17, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

09-17-26 1636ET

### Related Stocks

- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)

## Related News & Research

- [Bristol Myers Swoons on Test Results](https://longbridge.com/en/news/298335284.md)
- [BMS reports positive data from Phase II QUINTESSENTIAL study for r/r MM](https://longbridge.com/en/news/298442546.md)
- [McDonald's Stock Price Forecast: MCD Tumbles to 2022 Low, Will It Fall Further or Rebound?](https://longbridge.com/en/news/299996327.md)
- [Why McDonald's Stock Is Down Today — and Where Wall Street Sees It Going Next](https://longbridge.com/en/news/299924054.md)
- [Is Restaurant Upgrade Plan Altering The Investment Case For McDonald’s (MCD)?](https://longbridge.com/en/news/299948078.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**